Vident Advisory LLC Purchases New Shares in AdaptHealth Corp. $AHCO

Vident Advisory LLC bought a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 15,043 shares of the company’s stock, valued at approximately $163,000.

Other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC increased its holdings in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock worth $81,000 after purchasing an additional 4,758 shares in the last quarter. Brooklyn Investment Group grew its holdings in shares of AdaptHealth by 531.8% in the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock worth $82,000 after acquiring an additional 6,366 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in AdaptHealth during the first quarter valued at $114,000. Legato Capital Management LLC bought a new position in AdaptHealth in the first quarter valued at about $167,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in AdaptHealth by 25.3% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 15,871 shares of the company’s stock valued at $172,000 after acquiring an additional 3,208 shares during the period. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Performance

Shares of AHCO opened at $9.16 on Thursday. The business has a 50-day simple moving average of $9.32 and a two-hundred day simple moving average of $9.27. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.14. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.70. The stock has a market cap of $1.24 billion, a price-to-earnings ratio of 16.96, a PEG ratio of 1.03 and a beta of 1.59.

Insider Activity

In related news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares of the company’s stock, valued at approximately $486,937.85. This represents a 14.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.55% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded AdaptHealth from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.